Next-gen HR leaders are shifting to proactive health strategies that reduce absenteeism, lower insurance costs, and boost productivity. The problem? Most wellness programs fail to engage employees or improve outcomes. We are hosting a conversation with Function Health, one of the fastest-growing personal health platforms in the US. They've built something different: 5X more comprehensive testing than standard physicals, zero insurance approvals required, and direct employer partnerships with discounted rates. RSVP: Sign up here (https://lnkd.in/e7q6We8M).
Blue Ivy Ventures (an Alumni Ventures Fund)
Venture Capital and Private Equity Principals
Boston, MA 5,419 followers
An Alumni Ventures Fund and community for Yale alumni & friends.
About us
Blue Ivy Ventures is an Alumni Ventures' venture capital fund for alumni of Yale that invests in companies with a Yale connection. Meet the team: David Shapiro, Managing Partner Yevgeny Gelfand, Partner Ryan Musto, Senior Associate We are part of Alumni Ventures, America’s largest venture firm for individual investors. Founded in 2014, we are the venture investing partner to over 11,000 individuals and institutions. Follow Blue Ivy Ventures for content at the intersection of our shared alma mater, venture capital, and entrepreneurship. We are private, for-profit, and not affiliated with or sanctioned by the college. Offers of securities are made only to eligible investors through formal offering documents, which describe the risks, terms, and other important information that must be considered before investing. Example portfolio company investments shown for illustrative purposes only, do not necessarily reflect investment outcomes that were or would be obtained by any AV fund or investor, and are not available to future investors, except potentially in the case of follow-on investments. Venture capital investing involves substantial risk, including risk of loss of all capital invested. Past performance does not guarantee future results.
- Website
-
https://av-funds.com/3w0NsNE
External link for Blue Ivy Ventures (an Alumni Ventures Fund)
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 51-200 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 2016
- Specialties
- Venture Capital, Entrepreneurship, and Alumni Investing
Locations
-
Primary
Get directions
7 Post Office Square
6th Floor
Boston, MA 02110, US
Employees at Blue Ivy Ventures (an Alumni Ventures Fund)
-
David Shapiro
Founding Managing Partner at Blue Ivy Ventures, an Alumni Ventures fund
-
Natasha Walji
Managing Director @ Google | AI | McKinsey | Yale | Cambridge | Computer Science | Top 100 | Investor
-
Leslie Goldman Tepper
Board Member @ Deep Isolation, Berkeley Earth, Titan Acquisition Corp | Corporate Governance | Alternative Investments
-
John Norwood
Goldman Sachs 10KSB Business Advisor | Financial Architect | Change Leader | PDA-Certified Board Director | Long-Term Value & Impact Investor
Updates
-
We’re proud to share that our portfolio company, Elion, has announced a $9.3M seed round, led by NEA! Elion is building the go-to AI-powered research and intelligence platform for healthcare technology—helping health systems make smarter, faster decisions in an increasingly complex vendor landscape. Over 60% of U.S. health systems now use Elion’s vendor marketplace, and engagement continues to grow rapidly as provider organizations navigate the accelerating pace of healthcare innovation. We’re excited to support Elion as they expand their platform, grow their team, and continue delivering trusted insights to the healthcare ecosystem! 📰 View the full press release: https://lnkd.in/eAJBzDYd #HealthTech #Elion #HealthcareInnovation #SeedFunding #DigitalHealth
-
Congrats to Elion Health and Bobby Guelich on closing their seed round! It’s been a privilege to support the team thus far, and we are excited for their journey ahead.
I’m thrilled to share that Elion has raised an oversubscribed $9.3M seed round led by NEA, with participation from Cedars Sinai Health Ventures, TMV, Scrub Capital, and Alumni Ventures. Today, selecting the right technology has never mattered more. AI is transforming healthcare, and the organizations that can identify and adopt the right solutions will be the ones that thrive, while those that can’t risk falling behind operationally, financially, and clinically. Elion exists to help healthcare organizations navigate this technology-driven future. We’re building a research and intelligence platform that transforms how leaders discover, evaluate, and adopt new technology. By helping organizations cut through the market noise and focus on the right solutions, we’re improving how healthcare is delivered at scale. We’re still early in our journey, but the impact is already clear: More than 60% of U.S. health systems use our marketplace to discover and evaluate vendors. Leaders from top institutions rely on our research to make more informed technology decisions. Healthcare IT buyers are accelerating their processes through our curated events. And health systems are partnering with Elion to shape their AI strategies and guide their vendor decisions. This funding will accelerate our efforts, allowing us to increase our investments in the technology, data, and research that power the Elion platform. We believe better decisions about technology lead to better care, better operations, and better outcomes. That’s the future we’re working toward, and we’re proud to support the leaders and organizations making it possible. Thank you to Michael Li (New Enterprise Associates (NEA)), Matthew Weinberg and Ryan Darnell (Max Ventures), Maureen Burgess and Rohit Rajkumar (Cedars Sinai Health Ventures), Emma Silverman and Soraya Darabi (TMV ) Rebecca Mitchell, Jonathan Slotkin, and Christina Farr (Scrub Capital), Alumni Ventures, and Riverside Ventures for joining us on this journey. I’m grateful as well to our existing partners: AlleyCorp, Floating Point, Charge Ventures, Headwater Ventures, as well as our fantastic group of angels and advisors.
-
-
Portfolio company Precision Neuroscience has been recognized in Fast Company's 2025 World Changing Ideas Award list. Precision was honored alongside other businesses and organizations that are creating innovative solutions to today's most pressing challenges. You can explore the complete list of these groundbreaking companies below!
Precision Neuroscience has been named to Fast Company’s World Changing Ideas 2025 Award list! We’re honored to be recognized by Fast Company for the work we’re doing to advance the next generation of brain-computer interfaces, designed to enable users with paralysis to control digital devices—such as computers and smartphones—using only their thoughts. Read the full news release here: https://lnkd.in/efzWBbHt See the full Fast Company World Changing Ideas 2025 list here: https://lnkd.in/eZQEnfTQ #FCWorldChangingIdeas #WorldChangingIdeas #FastCompany #BrainComputerInterface #AIinHealthcare
-
-
Congrats to portfolio company Runwise on their $55M Series B! They’re the operating system transforming 10,000+ buildings into smart, sustainable systems. Its platform cuts fossil fuel usage and energy costs by an average of 20% in every building it touches, saving over $115,000,000 and counting. 10 thousand buildings down, 50 million to go. See how Runwise is scaling the smart city movement: https://lnkd.in/gyjS_VHa.
We’re excited to share that Runwise has raised $55M to accelerate the transformation of building infrastructure. This round includes a $30M Series B led by Menlo Ventures and $25M in new debt financing from Multiplier Capital. Huge thanks to Axios and Alan Neuhauser for covering the story: https://lnkd.in/gyjS_VHa This marks a major step toward our goal: making every building in the world smarter, safer, more energy efficient, and radically easier to operate. Runwise is now live in 10,000+ buildings across the U.S., helping owner-operators reduce energy use and costs by 20%+ on average, while improving reliability, comfort, and control. This round also saw participation from some of the world’s leading infrastructure and financial institutions including: MassMutual Ventures, Nuveen, a TIAA company, Munich Re, Soma Capital, Alumni Ventures, Helium-3 Ventures-3, Cooley LLP, and Fifth Wall. We’re proud to partner with more than 1,000 real estate leaders—from Related Companies, Equity Residential, and LeFrak to Metropolitan Transportation Authority, and The Port Authority of New York & New Jersey—who are rethinking what’s possible inside their buildings. So far, Runwise has: ✅ Delivered over $115M in energy cost savings ✅ Cut the equivalent of 100,000+ cars in carbon emissions ✅ Enabled entire building operating system to be installed in single day vs. weeks with legacy systems With this new funding, we’re scaling faster than ever—across the U.S. and globally—toward a future where intelligent infrastructure isn’t a luxury. It’s the default. To our customers, partners, and team: Thank you. We’re just getting started. 10,000 buildings down. 50 million to go. 🚀
-
Smart money doesn’t chase hype—it follows substance. That’s why ŌURA’s innovation and traction have drawn a powerful circle of investors, including AV. Delve into the sourcing, evaluation, and decision-making processes that led to our investment in Ōura: https://lnkd.in/geshjyxk.
-
What do Jennifer Aniston, the NBA, and 2.5 million others have in common? They all trust Oura. We saw ŌURA not as just a wearable but as a wedge into the future of #healthtech and invested before it became a household name. Discover the conviction, timing, and strategy behind our bet on this $5.2B force: https://lnkd.in/eFamBmF9.
-
-
Who gave tech kings the keys to your feed? Portfolio company Bluesky Social, led by CEO Jay Graber, is breaking the empire. Decentralized by design, Bluesky puts the power of social media back in the hands of its users: https://lnkd.in/eDzwVr-Z.
-
-
ŌURA's smart ring isn't just wearable tech; it's a $5.2B signal that health data is the new frontier. Join our May 20 masterclass to see why we backed this breakout. Register now: https://lnkd.in/ehWx5828.
-
-
.@ouraring smart ring isn't just wearable tech; it's a $5.2B signal that health data is the new frontier. Join our May 20 masterclass to see why we backed this breakout. Register now: https://lnkd.in/ehWx5828.
-